Expert consensus on radiotherapy for oligometastatic esophageal cancer (2025 edition)
Approximately 40% of esophageal cancer patients have metastatic disease at the time of initial diagnosis. Although immunotherapy has changed the treatment pattern of advanced, recurrent, or metastatic esophageal cancer, the options for systemic treatment for these patients are still limited, and the...
Saved in:
Format: | Article |
---|---|
Language: | English |
Published: |
Elsevier
2025-06-01
|
Series: | Radiation Medicine and Protection |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666555725000486 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic impact of body composition and immune-nutritional status in oligometastatic NSCLC patients receiving radiotherapy
by: Zhifei Huang, et al.
Published: (2025-07-01) -
Focused vascular ultrasound. Consensus of Russian experts
by: T. V. Balakhonova, et al.
Published: (2022-08-01) -
Preoperative radiotherapy in patients with locally advanced esophageal squamous cell carcinoma: a narrative review
by: Yan Lin, et al.
Published: (2025-07-01) -
Expert Consensus on Subxiphoid and Subcostal Arch Thoracoscopic Resection for the Treatment of Thymoma
by: Xunliang Yin, et al.
Published: (2025-06-01) -
Chinese Expert Consensus on Standardized Outpatient Management of Sarcopenia in the Elderly (2024)
by: Zhang Qin, et al.
Published: (2025-06-01)